ELF1 Transcription Factor Enhances the Progression of Glioma via ATF5 promoter-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ELF1 Transcription Factor Enhances the Progression of Glioma via ATF5 promoter

Published:2021-03-15 Issue:7 Volume:12 Page:1252-1261
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Hu Ming¹,Li Huanting²,Xie Hongwei²,Fan Mingchao²,Wang Jianpeng²,Zhang Niankai³,Ma Junwei²,Che Shusheng²^ORCID

Affiliation:

1. Department of Special Medicine, Basic Medicine College, Qingdao University, Qingdao, Shandong 266071, P. R. China

2. Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P. R. China

3. Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P. R. China

Funder

the Medical, Health Science and Technology Development Program of Shandong Province

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00070

Reference44 articles.

1. Glioma Subclassifications and Their Clinical Significance

2. Histologic classification of gliomas

3. Management of diffuse glioma

4. Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas

5. Genotype-targeted local therapy of glioma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions;Pharmacological Research;2024-10

2. A bird’s eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications;Cell Death & Disease;2024-09-11

3. POLE -related gene signature predicts prognosis, immune feature, and drug therapy in human endometrioid carcinoma;Heliyon;2024-04

4. IQGAP3 promotes the progression of glioma as an immune and prognostic marker;Oncology Research;2024

5. Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy;BMC Cancer;2023-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3